Introduction

nephritis.
Renal function declined rapidly. In September 1994 Thrombotic events are frequent among patients with the creation of a dialysis fistula was attempted. Within end-stage renal disease ( ESRD) [1] . In previous studies 3 weeks, four further interventions were required due changes of the coagulation system induced by chronic to recurrent thrombosis despite giving low-dose hephaemodialysis treatment have been identified as arin. Haemodialysis was initiated 1 month later and acquired risk factors for increased thrombophilia in was complicated by frequent clotting of the canula these patients [1, 2] . The impact of genetic throm-immediately after puncture that could not be prevented bophilic risk factors, however, remains unknown. In by flushing the needles with heparin. Using systemic the present case, we report on a female paediatric anticoagulation (heparin, 60 units/kg i.v.) via a peripatient suffering from severe thrombophilia on haemo-pheral vein at the contralateral arm prior to placing dialysis. In this patient the prothrombin mutation the needles, dialysis was possible without further G20210A has been identified as a genetic risk factor complications. for the development of recurrent fistula and needle
In December 1994 the patient received her first renal thrombosis. Early graft thrombosis has been reported transplant. After opening the anastomoses, a very in abstract form for another patient presenting the variable organ appearance was noted, with the colour same mutation [3] .
changing between rose and deep blue. Heparin was given within 30 min (150 units/kg bodyweight, i.v.), and was continued for 2 weeks. Immunosuppression Case included antithymocyte globulin for 2 days, methylprednisolone, azathioprine, and cyclosporin A. The The patient was born in 1982 to caucasian parents. postoperative course was uneventful except for two The family history was uneventful. In 1988, she had episodes of unexplained rise in serum creatinine and an unexplained hydrocephalus occlusus, possibly due fever followed by spontaneous, almost complete recovto mumps. After placement of a ventriculoperitoneal ery. A graft biopsy performed after the second episode shunt no neurological deficit was observed. The further showed inflammatory changes. history was uneventful until July 1993, when she Five months later, steroid-resistant interstitial rejecpresented with headache, arterial hypertension, and tion occurred. Treatment with tacrolimus was partially renal failure (creatinine 2 mg/dl ). No further abnor-successful, with a rise of the GFR from 28 to malities were detected on physical examination. 47 ml/min/1.73 m2 maintained for 7 months, followed Urinalysis showed mild proteinuria and haematuria. by a rapid decline in renal function. Biopsy of the Immunological work-up including complement system kidney transplant was done twice during this period and antibodies (ANA, cANCA, pANCA, anti-DNA) and revealed marked interstitial fibrosis. Haemodialysis was normal. No evidence for shunt nephritis was was reinstituted in August 1996 using a.v. fistula at found. The patient had not taken any medication the right upper arm. Again, thrombotic occlusion of except occasional analgetics for headache. A kidney the shunt occurred, cured by thrombectomy. The patient was given daily low-molecular-weight heparin 
The coagulation system was examined several times gene and revealed no evidence of thrombophilia. We Genomic DNA was extracted from peripheral blood by a excluded factor V Leiden mutation, deficiency of standard method [5] . A 142 bp fragment of the 3∞-antithrombin (94%), protein S (99%) and protein C untranslated region of the prothrombin gene was amplified (100%), homocystinaemia, lupus anticoagulant (kaolin by the PCR in a mixture of 54 mM Tris-HCl, pH 8.8, 1.5 clotting time, 0.0), and grossly elevated Lp(a) mM MgCl
2
, 10 mM of each dNTP, 500 ng of each primer (<12 mg%). Finally, the patient was screened for a described by Makris et al. In September 1997, the second renal transplantation present, there was no cleavage site for HindIII and the 142 was performed. The patient was anticoagulated with bp fragment remained intact. heparin (500-700 IE/kg/bodyweight) starting intraoperatively (150 IE/kg bodyweight). On the seventh day, Discussion severe bleeding in the transplant region occurred, necessitating blood transfusions. Kidney function was Generally, a tendency towards thrombosis is induced not compromised. After discharge, daily subcutaneous by increased activation of the clotting cascade or by low-molecular-weight heparin was continued. No fur-impaired anticoagulant or fibrinolytic mechanisms. ther thromboembolic complications were observed. Risk factors include hereditary and acquired condiImmunosuppression included methylprednisolone, tions. The first genetic risk factors for thrombosis were mycophenolate-mofetil, and cyclosporin A. Six months identified in families in whom the thrombophilia after kidney transplantation, the creatinine clearance segregated with an abnormal result in a plasma test is stable at 116 ml/min/1.73 m2.
(protein C and S, antithrombin, and APC resistance) [4] . None of these disorders, nor acquired risk factors except ESRD could be detected in our patient.
Recently, a single-point mutation of the prothrombin gene leading to the substitution of G by A at position 20210 has been described to be an independent risk factor for the development of venous thrombosis [4, 7, 8] . The G20210A mutation is located in the 3∞-untranslated region of the prothrombin gene. An association was found between the presence of the G20210A allele and elevated prothrombin levels [4] . Elevated prothrombin itself is known to be a risk factor for venous thrombosis. The mechanism by which this mutation leads to increased plasma levels of prothrombin is unclear, but a higher stability of the transcribed mRNA has been suspected [4] .
Homozygous G20210A mutation has been described in a patient with massive thrombosis leading to myocardial infarction, and subsequent ileofemoral venous thrombosis and massive saddle pulmonary embolus [7] . The common hemizygous state [4] is associated with mild thrombophilia restricted to the venous system. Thrombosis outside the veins in hemizygous subjects has only been described in two patients with ESRD, ours and the patient reported by Oh et al. [3] . We speculate that the association of the G20210A the 3∞-untranslated region of the wild-type prothrombin gene, a mutation and ESRD greatly increases the thrombotic single band at 142 bp occurred without any HindIII digestion site. risk.
However, the HindIII digestion of the patient's PCR product resulted
The optimal strategy to prevent thrombosis in these in an additional band at 124 bp, indicating a heterozygous state. 1, bp scale; 2, wild-type gel electrophoresis; 3, patient's DNA. patients is not yet defined. During the haemodialysis
